Finance

Article


<div class="articleContainer">
<div class="articleWrapper">
<div class="articleContent">
<h1 class="text title" doc-editable="text" data-component-id="doc-1fh3me1dm0">March 8 Quick Takes: Blackstone backs DNAnexus with $200M</h1><h2 class="title-bottom webtitle" doc-editable="title" data-component-id="doc-1fh3men3r0">Plus Sherlock raises $80M and updates from WuXi AppTec, Mustang, UroGen and more</h2><div class="byline ng-tns-c17-4 ng-star-inserted" data-component-id="doc-1fh3me7lj0">
    <span class="ng-tns-c17-4" doc-editable="text">By BioCentury Staff</span>
</div><div class="date" data-component-id="doc-1fh3mec8j0">
  <span class="byline" doc-editable="text"></span>
</div></div></div></div>


DNAnexus Inc.

Sherlock Biosciences Inc.

Oxeon Partners

Mustang Bio Inc.

UroGen Pharma Ltd.

TRex Bio Inc.

WuXi AppTec Co. Ltd.

Valneva SE

Cognito Therapeutics Inc.

Aetion Inc.

University of Cambridge

DIOSynVax Inc.

Creyon Bio Inc.

Mytide Therapeutics Inc.

March 8 Quick Takes: Blackstone backs DNAnexus with $200M

Plus Sherlock raises $80M and updates from WuXi AppTec, Mustang, UroGen and more

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

China Healthcare Summit

Bio€quity Europe

The BioCentury Show

Events

My Workspace

Company Overview

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Trial

Subscribe

Advertising & Sponsorship

Career Opportunities

Customer Resource Center

Contact

Home

<br/><br/><center><span style="font-size:1.75rem;font-weight:500;">Access this Article</span></center>